1. S56 ZFP36L1 and ZFP36L2 deficiency contribute to steroid refractoriness and epithelial remodelling in severe asthma. (11th November 2022) Authors: Rynne, J; Ortiz-Zapater, E; Ponde, N; Khooshemehri, P; Plate, M; Bucca, G; Smith, C; Chambers, R; Martinez-Nunez, RT Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S58 UPF1 is a novel modulator of antiviral responses against rhinovirus and is deficient in patients with severe asthma. (11th November 2022) Authors: Richardson, A; Ponde, N; Ong, S; Khooshemehri, P; Bagley, D; Bucca, G; Hesketh, A; Smith, C; Rosenblatt, J; Martinez-Nunez, RT Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tocilizumab for severe COVID-19 pneumonia. (November 2020) Authors: Piano, Salvatore; Vettor, Roberto; Angeli, Paolo; Arcidiacono, G; Benfaremo, D; Bettini, S; Bonora, BM; Bucca, G; Cattelan, A; Cerruti, L; Dalbeni, A; Framba, V; Gabrielli, A; Gambino, CG; Ghirardini, F; Gnudi, U; Luchetti, MM; Mantovani, A; Mareso, S; Marini, M Journal: Lancet Issue: Volume 2:Number 11(2020) Page Start: e659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗